Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ARS Pharmaceuticals (SPRY) Cash from Investing Activities (2021 - 2025)

ARS Pharmaceuticals (SPRY) has disclosed Cash from Investing Activities for 5 consecutive years, with $24.1 million as the latest value for Q4 2025.

  • Quarterly Cash from Investing Activities rose 123.7% to $24.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $56.8 million through Dec 2025, up 153.5% year-over-year, with the annual reading at $56.8 million for FY2025, 153.5% up from the prior year.
  • Cash from Investing Activities hit $24.1 million in Q4 2025 for ARS Pharmaceuticals, up from -$45.0 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $48.6 million in Q2 2025 to a low of -$111.5 million in Q1 2023.
  • Historically, Cash from Investing Activities has averaged -$6.8 million across 5 years, with a median of -$32500.0 in 2021.
  • Biggest YoY gain for Cash from Investing Activities was 204509.09% in 2023; the steepest drop was 531071.43% in 2023.
  • Year by year, Cash from Investing Activities stood at $40.7 million in 2021, then tumbled by 100.31% to -$126000.0 in 2022, then soared by 20765.87% to $26.0 million in 2023, then tumbled by 490.8% to -$101.8 million in 2024, then skyrocketed by 123.7% to $24.1 million in 2025.
  • Business Quant data shows Cash from Investing Activities for SPRY at $24.1 million in Q4 2025, -$45.0 million in Q3 2025, and $48.6 million in Q2 2025.